PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+3.74%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.13B
AUM Growth
-$145M
(-6.4%)
Cap. Flow
-$167M
Cap. Flow
% of AUM
-7.82%
Top 10 Holdings %
Top 10 Hldgs %
25.78%
Holding
1,594
New
34
Increased
419
Reduced
857
Closed
284
Top Buys
| 1 |
Gilead Sciences
GILD
|
$6.62M |
| 2 |
Apple
AAPL
|
$5.98M |
| 3 |
Amgen
AMGN
|
$5.55M |
| 4 |
Microsoft
MSFT
|
$4.92M |
| 5 |
AbbVie
ABBV
|
$4.44M |
Top Sells
| 1 |
Exxon Mobil
XOM
|
$5.14M |
| 2 |
Schlumberger
SLB
|
$3.43M |
| 3 |
Freeport-McMoran
FCX
|
$2.81M |
| 4 |
Chevron
CVX
|
$2.78M |
| 5 |
Duke Energy
DUK
|
$2.5M |
Sector Composition
| 1 | Healthcare | 31.2% |
| 2 | Technology | 14.82% |
| 3 | Energy | 7.97% |
| 4 | Financials | 7.89% |
| 5 | Communication Services | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
NetApp
NTAP
$23.7B
| $1.22M | 0.06% |
28,377
+2,568
| +10% | +$110K |
|
327
CF Industries
CF
$13.7B
| $1.21M | 0.06% |
21,715
-5,020
| -19% | -$280K |
|
328
Oceaneering
OII
$2.41B
| $1.21M | 0.06% |
18,605
-7,138
| -28% | -$465K |
|
329
Barclays
BCS
$69.1B
| $1.21M | 0.06% |
87,884
-50,612
| -37% | -$697K |
|
330
HF Sinclair
DINO
$9.56B
| $1.2M | 0.06% |
27,473
-17,252
| -39% | -$754K |
|
331
Ashland
ASH
$2.51B
| $1.19M | 0.06% |
23,377
-13,623
| -37% | -$694K |
|
|
WX
332
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $1.19M | 0.06% |
34,016
+3,457
| +11% | +$121K |
|
|
S
333
DELISTED
Sprint Corporation
S
| $1.19M | 0.06% |
187,608
-15,138
| -7% | -$95.9K |
|
334
Nokia
NOK
$24.5B
| $1.18M | 0.06% |
139,995
-79,605
| -36% | -$673K |
|
335
Chubb
CB
$111B
| $1.18M | 0.06% |
11,222
+1,151
| +11% | +$121K |
|
336
Wolfspeed
WOLF
$196M
| $1.17M | 0.05% |
28,642
-4,746
| -14% | -$194K |
|
337
General Dynamics
GD
$86.8B
| $1.16M | 0.05% |
9,158
-118
| -1% | -$15K |
|
338
Charles Schwab
SCHW
$167B
| $1.16M | 0.05% |
39,571
+5,570
| +16% | +$164K |
|
339
IAC Inc
IAC
$2.98B
| $1.14M | 0.05% |
96,756
-11,448
| -11% | -$135K |
|
340
Charter Communications
CHTR
$35.7B
| $1.14M | 0.05% |
7,518
+854
| +13% | +$129K |
|
|
MR
341
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
| $1.14M | 0.05% |
37,748
+4,372
| +13% | +$132K |
|
342
Hanesbrands
HBI
$2.27B
| $1.13M | 0.05% |
42,032
-16,232
| -28% | -$436K |
|
343
Tenaris
TS
$18.2B
| $1.13M | 0.05% |
24,786
-14,094
| -36% | -$642K |
|
|
SUNE
344
DELISTED
SUNEDISON, INC COM
SUNE
| $1.13M | 0.05% |
59,726
-11,546
| -16% | -$218K |
|
345
Autodesk
ADSK
$69.5B
| $1.11M | 0.05% |
20,215
+2,509
| +14% | +$138K |
|
|
CNVR
346
DELISTED
CONVERSANT INC COM STK (DE)
CNVR
| $1.11M | 0.05% |
32,386
-10,032
| -24% | -$344K |
|
347
New Oriental
EDU
$7.98B
| $1.11M | 0.05% |
47,692
+6,970
| +17% | +$162K |
|
348
UDR
UDR
$13B
| $1.11M | 0.05% |
40,578
-18,302
| -31% | -$499K |
|
|
CHA
349
DELISTED
China Telecom Corporation, LTD
CHA
| $1.1M | 0.05% |
17,889
+2,961
| +20% | +$182K |
|
350
GSK
GSK
$81.6B
| $1.1M | 0.05% |
19,094
-10,858
| -36% | -$624K |
|